Aims and scope
Lupus Science & Medicine is a global, peer reviewed, Open Access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus.
The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.
Lupus Science & Medicine is published by BMJ and owned by the Lupus Foundation of America, which is dedicated to advancing the science and medicine of lupus while offering support to patients and their caregivers.
Continuous online publication
52% for original research articles
Mean time from submission to first decision
Mean time from acceptance to online publication
Google Scholar, PubMed Central
For all contact information please refer to the contact us page.
Please refer to the Instructions for authors
Rights and permissions
Lupus Foundation of America
The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.